These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35469839)

  • 21. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.
    Tarangelo A; Magtanong L; Bieging-Rolett KT; Li Y; Ye J; Attardi LD; Dixon SJ
    Cell Rep; 2018 Jan; 22(3):569-575. PubMed ID: 29346757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
    Shetake NG; Das SK; Kumar A; Pandey BN
    Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
    Guan Z; Chen J; Li X; Dong N
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear export of PML promotes p53-mediated apoptosis and ferroptosis.
    Ni Y; Chen H; Zhan Q; Zhuang Z
    Cell Signal; 2024 Sep; 121():111278. PubMed ID: 38944257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells.
    Synnott NC; O'Connell D; Crown J; Duffy MJ
    Breast Cancer Res Treat; 2020 Jan; 179(1):47-56. PubMed ID: 31538264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiliroside induces ferroptosis to repress the development of triple-negative breast cancer cells.
    Hu C; Zhao JF; Wang YM; Wu XL; Ye L
    Tissue Cell; 2023 Aug; 83():102116. PubMed ID: 37301139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new pyrrole based small molecule from Tinospora cordifolia induces apoptosis in MDA-MB-231 breast cancer cells via ROS mediated mitochondrial damage and restoration of p53 activity.
    Rashmi KC; Harsha Raj M; Paul M; Girish KS; Salimath BP; Aparna HS
    Chem Biol Interact; 2019 Feb; 299():120-130. PubMed ID: 30543781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation.
    He G; Zhang Y; Feng Y; Chen T; Liu M; Zeng Y; Yin X; Qu S; Huang L; Ke Y; Liang L; Yan J; Liu W
    J Cell Mol Med; 2024 Apr; 28(7):e18212. PubMed ID: 38516826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
    Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
    J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superoxide-mediated ferroptosis in human cancer cells induced by sodium selenite.
    Subburayan K; Thayyullathil F; Pallichankandy S; Cheratta AR; Galadari S
    Transl Oncol; 2020 Nov; 13(11):100843. PubMed ID: 32805675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin.
    NaveenKumar SK; Hemshekhar M; Kemparaju K; Girish KS
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2303-2316. PubMed ID: 31102787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
    Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
    J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron Overload Causes Ferroptosis But Not Apoptosis in MO3.13 Oligodendrocytes.
    Li Y; Wang B; Yang J; Liu R; Xie J; Wang J
    Neurochem Res; 2023 Mar; 48(3):830-838. PubMed ID: 36352276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.
    Hu J; Zhang Y; Jiang X; Zhang H; Gao Z; Li Y; Fu R; Li L; Li J; Cui H; Gao N
    J Exp Clin Cancer Res; 2019 May; 38(1):225. PubMed ID: 31138329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
    Mokhtarpour K; Razi S; Rezaei N
    Breast Cancer Res Treat; 2024 Oct; 207(3):497-513. PubMed ID: 38874688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer.
    Takatani-Nakase T; Ikushima C; Sakitani M; Nakase I
    Life Sci; 2024 Feb; 339():122411. PubMed ID: 38184272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
    Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
    Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
    [No Abstract]   [Full Text] [Related]  

  • 38. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
    Wang Y; Sun Y; Wang F; Wang H; Hu J
    Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
    Li J; He D; Li S; Xiao J; Zhu Z
    Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diplacone Isolated from
    Kang MJ; Ryu HW; Oh ES; Song YN; Huh YH; Park JY; Oh SM; Lee SY; Park YJ; Kim DY; Ro H; Hong ST; Lee SU; Moon DO; Kim MO
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.